CAS: 176983-21-4

2α,19α-dihydroxy-3-oxo-urs-12-en-28-oic acid inhibits HIV, EBV-EA activation, and delays mouse skin carcinogenesis.

1,11-Dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-2H-picene-4a-carboxylic acid is a highly complex triterpenoid compound. This product is a natural derivative, generally identified in specific plant sources such as certain medicinal herbs that synthesize triterpenoids as part of their secondary metabolic processes. The compound exhibits a specific mode of action by integrating into hydrophobic cell membrane domains, potentially influencing membrane fluidity and impacting cellular signaling pathways. In scientific research, it is utilized for studying various biochemical and medicinal interactions due to its complex structure and potential bioactivity. Its applications are significant in understanding the pharmacokinetics and pharmacodynamics of triterpenoid compounds, especially in relation to their roles in modulating enzyme activities, potential anticancer properties, and impacts on cholesterol metabolism. Such compounds are invaluable in leading to the synthesis of analogs with potentially enhanced therapeutic profiles. Researchers focus on its potential applications in cell culture models and its use as a reference compound in chromatographic analysis.